Bittium Oyj - Decisions of general meeting

Decisions of the Annual General Meeting of Bittium Corporation

Stock exchange release

Free for publication on April 12, 2017 at 4.00pm (CEST+1)

Decisions of the Annual General Meeting of Bittium Corporation

The Annual General Meeting of Bittium Corporation was held on April 12, 2017, at
1.00pm at the address the University of Oulu, Saalastinsali, Pentti Kaiteran
katu 1, 90590 Oulu, Finland. The Annual General Meeting approved the annual
accounts for the financial year 2016 and discharged the company's management
from liability.

USE OF THE PROFITS SHOWN ON THE BALANCE SHEET AND PAYMENT OF DIVIDEND

The Annual General Meeting decided in accordance with the proposal of the Board
of Directors to pay EUR 0.05 per share as dividend and EUR 0.25 per share as
additional dividend based on the adopted balance sheet for the financial period
January 1, 2016 – December 31, 2016. The dividend will be paid to the
shareholders who are registered as shareholders in the company's register of
shareholders as maintained by Euroclear Finland Ltd on the dividend record date
Tuesday, April 18, 2017. The dividend will be paid on Tuesday, April 25, 2017.

ELECTION AND REMUNERATION OF THE MEMBERS OF THE BOARD OF DIRECTORS

The Annual General Meeting decided that the Board of Directors shall comprise
six (6) members. Ms. Kirsi Komi, Mr. Seppo Mäkinen, Mr. Juha Putkiranta, Mr.
Staffan Simberg and Mr. Erkki Veikkolainen were re-elected as members of the
Board of Directors for a term of office expiring at the end of the next Annual
General Meeting. Further, Mr. Tero Ojanperä was elected as a new member of the
Board of Directors for a corresponding term of office.

At its assembly meeting held on April 12, 2017, the Board of Directors has
elected Mr. Erkki Veikkolainen Chairman of the Board. Further, the Board has
resolved to keep the Audit Committee. Staffan Simberg (Chairman of the
committee) and Kirsi Komi were elected as members of the Audit Committee and
authorized public accountant Seppo Laine was invited to the Audit Committee as
external advisor of the Board of Directors.

The following monthly remuneration shall be paid to the members of the Board of
Directors: to the chairman of the Board of Directors EUR 3,500 and to the other
members of the Board of Directors EUR 2,000 each. In addition, the members of
the Board of Directors are entitled to compensation for attending Board
Committee meetings as follows: the chairman of the Committee EUR 600 for each
meeting and other Committee members EUR 400 for each meeting. Travel expenses of
the members of the Board of Directors shall be reimbursed in accordance with the
Company's travel policy. The General Meeting also decided that 40 per cent of
the total amount of the monthly remuneration will be paid at once as Bittium
Corporation's shares acquired for the price formed in public trading, and the
shares will be acquired according to the share purchase program of the company.

ELECTION AND REMUNERATION OF THE AUDITOR

Ernst & Young Oy, authorized public accountants, was re-elected auditor of the
Company for a term of office ending at the end of the next Annual General
Meeting. Ernst & Young Oy has notified that Mr. Juhani Rönkkö, authorized public
accountant, will act as responsible auditor. It was decided that the
remuneration to the auditor shall be paid against the auditor's reasonable
invoice.

AUTHORIZING THE BOARD OF DIRECTORS TO DECIDE ON THE REPURCHASE OF THE COMPANY'S
OWN SHARES

The General Meeting authorized the Board of Directors to decide on the
repurchase of the Company's own shares as follows.

The amount of own shares to be repurchased shall not exceed 3,500,000 shares,
which corresponds to approximately 9.81 per cent of all of the shares in the
company. Only the unrestricted equity of the company can be used to repurchase
own shares on the basis of the authorization.

Own shares can be repurchased at a price formed in public trading on the date of
the repurchase or otherwise at a price formed on the market.

The Board of Directors decides how own shares will be repurchased. Own shares
can be repurchased using, inter alia, derivatives. Own shares can be repurchased
otherwise than in proportion to the shareholdings of the shareholders (directed
repurchase).

The authorization cancels the authorization given by the General Meeting on
April 19, 2016 to decide on the repurchase of the company's own shares.

The authorization is effective until June 30, 2018.

AUTHORIZING THE BOARD OF DIRECTORS TO DECIDE ON THE ISSUANCE OF SHARES AS WELL
AS THE ISSUANCE OF SPECIAL RIGHTS ENTITLING TO SHARES

The General Meeting authorized the Board of Directors to decide on the issuance
of shares and special rights entitling to shares referred to in Chapter 10
Section 1 of the Companies Act as follows.

The amount of shares to be issued shall not exceed 7,000,000 shares, which
corresponds to approximately 19.61 per cent of all of the shares in the company.

The Board of Directors decides on all the conditions of the issuance of shares
and of special rights entitling to shares. The authorization concerns both the
issuance of new shares as well as the transfer of treasury shares. The issuance
of shares and of special rights entitling to shares may be carried out in
deviation from the shareholders' pre-emptive rights (directed issue).

The authorization cancels the authorization given by the General Meeting on
April 19, 2016 to decide on the issuance of shares as well as the issuance of
special rights entitling to shares referred to in Chapter 10 Section 1 of the
Companies Act.

The authorization is effective until June 30, 2018.

Oulu, April 12, 2017
Bittium Corporation
The Board of Directors

Further information:

Hannu Huttunen
CEO
Tel. +358 40 344 3507

Kari Jokela
Chief Legal Officer
Tel. + 358 40 344 5258

Distribution:

Nasdaq Helsinki Ltd
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and
connectivity solutions leveraging its 30 year legacy of expertise in advanced
radio communication technologies. Bittium provides innovative products and
services, customized solutions based on its product platforms and R&D services.
Complementing its communications and connectivity solutions, Bittium offers
proven information security solutions for mobile devices and portable computers.
Starting from November 10th, Bittium offers its customers also healthcare
technology products and services in biosignal measuring in the areas of
cardiology, neurology, rehabilitation, occupational health and sports medicine.
Net sales in 2016 was EUR 64.2 million and operating profit was EUR 2.5 million.
Bittium is listed on Nasdaq Helsinki. www.bittium.com.

Viðhengi:

04121307.pdf